These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6098365)

  • 1. Phase II trial of 13-cis-retinoic acid in patients with advanced nonseminomatous germ cell tumors.
    Gold EJ; Bosl GJ; Itri LM
    Cancer Treat Rep; 1984 Oct; 68(10):1287-8. PubMed ID: 6098365
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of 1,2-diaminocyclohexane-(4-carboxyphthalato) platinum(II) in patients with refractory germ cell tumors.
    Chun H; Bosl GJ; Golbey RB
    Cancer Treat Rep; 1985 Apr; 69(4):459-60. PubMed ID: 2986834
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of oral medroxyprogesterone acetate in advanced germ cell tumors.
    Cavalli F; Klepp O; Hansen H; Rozencweig M
    Cancer Treat Rep; 1983 Oct; 67(10):953-4. PubMed ID: 6313188
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial.
    Drasga RE; Williams SD; Einhorn LH; Birch R
    Cancer Treat Rep; 1987 Sep; 71(9):863-4. PubMed ID: 3040247
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of mitoguazone in patients with refractory germ cell tumors.
    Chun H; Bosl GJ
    Cancer Treat Rep; 1985 Apr; 69(4):461-2. PubMed ID: 2986835
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group.
    Williams SD; Birch R; Gams R; Irwin L
    Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593
    [No Abstract]   [Full Text] [Related]  

  • 7. The antiemetic effect of methylprednisolone in patients treated with cis-platinum (CDDP) for advanced testicular germ cell tumors.
    Salvioni R; Faustini M; Piva L; Pasi M; Pizzocaro G
    Chemioterapia; 1984 Aug; 3(4):223-6. PubMed ID: 6099753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful chemotherapy for advanced nonseminomatous germ-cell tumor in a patient undergoing chronic hemodialysis.
    Froehner M; Passauer J; Schuler U; Hakenberg OW; Wirth MP
    J Clin Oncol; 2007 Apr; 25(10):1282-4. PubMed ID: 17401020
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of adjuvant chemotherapy in patients with stage II nonseminomatous germ-cell tumors.
    Motzer RJ; Bosl GJ
    Urol Clin North Am; 1993 Feb; 20(1):111-6. PubMed ID: 8381992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
    Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testicular tumors: delay in diagnosis and influence on survival.
    Prout GR; Griffin PP
    Am Fam Physician; 1984 May; 29(5):205-9. PubMed ID: 6328963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of primary chemotherapy in stage I and low-volume stage II nonseminomatous germ-cell testis tumors.
    Sternberg CN
    Urol Clin North Am; 1993 Feb; 20(1):93-109. PubMed ID: 8382000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular germ cell tumors in childhood: treatment results of 52 patients.
    Güler E; Tezer Kutluk M; Büyükpamukçu N; Caglar M; Varan A; Akyüz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2004; 21(1):49-56. PubMed ID: 14660306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonseminomatous germ cell tumor after chemotherapy with residual mass invading the spine.
    Berglund RK; Lyden SP; Tsai EC; Lieberman I; Klein EA
    Eur Urol; 2006 Aug; 50(2):372-4. PubMed ID: 16626860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy of testicular tumors].
    Cortes Funes H; Leiva Galvis O
    Actas Urol Esp; 1981; 5(5):259-72. PubMed ID: 6174033
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of the postchemotherapy residual mass.
    Sheinfeld J; Bajorin D
    Urol Clin North Am; 1993 Feb; 20(1):133-43. PubMed ID: 8381994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of stage I nonseminomatous testicular cancer with one cycle of adjuvant chemotherapy].
    Corti Ortíz D; Fonerón Burgos A; Troncoso Schifferli L
    Actas Urol Esp; 1997; 21(10):961-3. PubMed ID: 9494159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of ifosfamide in one-agent chemotherapy of malignant testicular tumors].
    Madej G; Porwit-Ksiazek A; Siedlecki P; Zborzil J
    Pol Tyg Lek; 1982 Jul; 37(24-25):717-9. PubMed ID: 6294642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.